Therapeutic use of anti-CS1 antibodies

Details for Australian Patent Application No. 2011200999 (hide)

Owner Abbott Biotherapeutics Corp.

Inventors Powers, David B.; Law, Debbie; Liu, Gao; Tso, J. Yun; Williams, Marna; Landolfi, Nicholas F.; Dubridge, Robert B.

Agent Davies Collison Cave

Pub. Number AU-B-2011200999

Parent 2004318675

Filing date 7 March 2011

Wipo publication date 31 March 2011

Acceptance publication date 31 May 2012

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

Event Publications

24 March 2011 Complete Application Filed

31 March 2011 Application Open to Public Inspection

  Published as AU-B-2011200999

31 May 2012 Application Accepted

  Published as AU-B-2011200999

27 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011201000-Reduced pressure delivery system having a manually-activated pump for providing treatment to low-severity wounds

2011200998-Fluid heating and storage tank and system; and pump therefor